QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 0.19034
-- x --
-- x --
-- - --
$ 0.12 - $ 0.28
5,800
na
na
$ 0.83
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 worlds-largest-tobacco-company-is-investing-in-medical-cannabis-heres-what-to-know

Philip Morris is expanding its medical cannabis strategy via Aurora and Avicanna. What it means for the future of Big Tobacco i...

 this-week-in-cannabis-carmelos-ny-launch-federal-reform-cancer-study-avicannas-growth-tilrays-split-desantis-fallout-slovenias-big-move-and-more

Cannabis news this week: Congress revives cannabis reform, Slovenia leads Europe, Tyson takes charge and science backs cannabis...

 why-cannabis-focused-biopharma-co-avicanna-traded-up-26-today

Shares of Avicanna Inc.

 the-week-in-cannabis-delays-decreesand-deals-reshape-the-global-playbook

Cannabis news of the week: Germany holds CanG, US delays, Chile bill; Italy hemp ban; SNDL expands, Tilray cuts outlook, US sal...

 this-week-in-cannabis-rescheduling-delays-the-dea-bidens-clemency-philip-morris-new-bet-and-more

Cannabis news: DEA delays reform hearings, Florida renews legalization push and global markets expand.

 avicanna-secures-nearly-2m-in-private-placement-deal-amid-us-patent-win-for-cannabinoid-topical-formula

Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that it has closed a non-brokered private placement o...

 avicanna-secures-us-patent-for-topical-cannabinoid-technology-to-treat-pain-and-inflammation

Avicanna secures a U.S. patent for its innovative deep penetrating topical cannabinoid composition for treating pain and inflam...

 avicannas-cbg-products-reach-19-countries-denmark-joins-global-expansion

Avicanna Inc. (OTC: AVCNF) biopharmaceutical company announced Thursday the successful export of its Aureus-branded cannabigero...

 latest-cannabis-hires-and-board-changes-heres-what-you-need-to-know

Cannabis ancillary company EnWave Corporation (TSX-V: ENW) (FSE: E4U) announced on Thursday that it had tapped Danna Dunnage as...

 avicanna-exports-cannabinoids-to-singapore-legally--even-though-cannabis-is-punishable-by-death-in-the-country

Cannabinoid-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that th...

 cbd-focused-avicanna-reports-first-ever-adjusted-ebitda-positive-quarter-451-yoy-spike-in-q1-record-revenue

Cannabis-focused biopharmaceutical company Avicanna Inc. announced on Tuesday financial results for the first quarter of fiscal...

 cbd-helps-with-this-rare-blistering-skin-disorder-new-study-from-avicanna-shows-promising-results-in-epidermolysis-bullosa-treatment

There is no cure for a rare blistering skin disorder called Epidermolysis Bullosa (EB). But, treatments to help alleviate and c...

 cannabinoid-based-products-maker-sees-triple-digit-growth-in-2023-gross-profit-revenue-surges-314-yoy

Cannabinoids-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) reported on Tuesday year-end...

 this-company-is-bringing-medical-marijuana-telehealth-to-over-half-the-us

MMJ.com, a telehealth platform providing access to medical marijuana, has expanded its services to 26 states. This expansion al...

 can-cannabis-treat-severe-forms-of-epilepsy-new-medicine-sparks-hope-as-colombias-weed-industry-goes-global

Clever Leaves Holdings Inc.

 cbd-focused-avicanna-announces-funding-boost-for-research-and-development

Cannabinoid-based biopharmaceutical company Avicanna Inc.

 avicanna-inc-medical-marijuana-sales-reach-record-713-yoy-growth-in-q3-introduces-new-platform

Avicanna Inc. (OTCQX: AVCNF) a biopharmaceutical company specializing in proprietary cannabinoid-based products, announced Q3 2...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION